J. Kuby and . Immunology, , 2016.

R. Référentiel, , 2016.

P. Groupe-de-travail-sor-:-ruffié, G. Gory-delabaere, B. Fervers, M. Lehmann, J. F. Regnard et al., Options et Recommandations pour la prise en charge des patients atteints de tumeurs épithéliales du thymus, vol.86, 1999.

N. Girard, E. Ruffini, A. Marx, C. Faivre-finn, and S. Peters, Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, p.26, 2015.

E. A. Engels, Epidemiology of thymoma and associated malignancies, J Thorac Oncol, 2010.

C. Buckley, D. Douek, J. Newsom-davis, A. Vincent, N. Wilcox et al.,

, CD8+ T cells are generated by the thymoma in myasthenia gravis, Ann Neurol, vol.50, pp.64-72, 2001.

J. V. Souadjian, P. Enriquez, M. N. Silverstein, and J. Pépin, The spectrum of diseases associated with thymoma, Arch Intern Med, vol.134, pp.374-79, 1974.

T. Fukui and K. Yokoi, The new classifications for thymic epithelial tumors: benefits and problems, J Thorac Dis, vol.9, issue.11, p.4168, 2017.

A. Marx, P. Ströbel, S. S. Badve, L. Chalabreysse, J. K. Chan et al., ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting, J Thorac Oncol, 2014.

N. Sakakura, H. Tateyama, S. Nakamura, T. Taniguchi, and N. Usami,

K. and Y. K. , Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification: note for thoracic clinicians, Gen Thorac Cardiovasc Surg, 2013.

, Feb, vol.61, issue.2, pp.89-95

S. Suster and C. A. Moran, Thymoma classification: current status and future trends, Am J Clin Pathol, vol.125, issue.4, pp.542-54, 2006.

J. Regnard, P. Magdeleinat, and C. Dromer, Prognostic factors and long-term results after thymoma resection: a series of 307 patients, J Thorac Cardiovasc Surg, vol.112, pp.376-384, 1996.

K. Koga, Y. Matsuno, M. Noguchi, K. Mukai, H. Asamura et al., A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma, Pathol Int, vol.44, issue.5, pp.359-67, 1994.

J. Huang, A new staging system for thymoma--will it improve outcomes?, J Thorac Cardiovasc Surg, vol.151, pp.20-22, 2016.

A. Meurgey, N. Girard, M. Du-vignaux, C. Maury, J. M. Tronc et al.,

L. Chalabreysse, Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors, J Thorac Oncol, vol.12, issue.10, pp.1571-1581, 2017.

F. C. Detterbeck, A. G. Nicholson, and K. Kondo, The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms, J Thorac Oncol, vol.6, pp.1710-1716, 2011.

F. C. Detterbeck, K. Stratton, and D. Giroux, The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors, J Thorac Oncol, vol.9, pp.65-72, 2014.

E. Davenport and R. A. Malthaner, The role of surgery in the management of Thymoma: a systematic review, Ann Thorac Surg, vol.86, pp.673-84, 2008.

P. Levasseur, A. Khalil, and M. Menestrier, First intensive radical exeresis surgery in invasive thymomas-results from a serie of 284 operated thymomas, 1989.

S. Attaran, M. Acharya, and J. R. Anderson, Does surgical debulking for advanced stages of thymoma improve survival?, Interact Cardiovasc Thorac Surg, vol.15, pp.494-501, 2012.

A. Toker, J. Sonett, and M. Zielinski, Standard Terms, Definitions and Policies for Minimally Invasive Resection of Thymoma, J Thoracic Oncol, vol.6, pp.1739-1781, 2011.

F. Grassin, N. Paleiron, and M. André, Combined etoposide, ifosfamide and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: a French experience

, J Thorac Oncol, vol.5, pp.893-900, 2010.

N. Girard, E. Ruffini, A. Marx, C. Faivre-finn, and S. Peters, Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, p.26, 2015.

N. Girard, E. Ruffini, A. Marx, C. Faivre-finn, and S. Peters, Ann Oncol, issue.5, pp.40-55, 2015.

R. J. Korst, A. L. Kansler, P. J. Christos, and S. Mandal, Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis, Ann Thorac Surg, vol.87, pp.1641-1648, 2009.

P. J. Loehrer, . Sr, K. Kim, and S. C. Aisner, Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group, J Clin Oncol, vol.12, pp.1164-1172, 1994.

D. Gomez, R. Komaki, and J. Yu, Radiation therapy definitions and reporting guidelines for thymic malignancies, J Thorac Oncol, vol.6, pp.1743-1751, 2011.

C. D. Fuller, E. H. Ramahi, and N. Aherne, Radiotherapy for thymic neoplasms, J Thorac Oncol, vol.5, pp.327-362, 2010.

G. Zhu, S. He, and X. Fu, Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients, Int J Radiat Oncol Biol Phys, vol.60, pp.1113-1122, 2004.

D. Gomez, R. Komaki, and J. Yu, Radiation therapy definitions and reporting guidelines for thymic malignancies, J Thorac Oncol, vol.6, pp.1743-1751, 2011.

M. W. Jackson, The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma, J Thorac Oncol, 2017.

J. Liao, The role of postoperative radiation therapy for completely resected stage III thymoma and e ect of higher heart radiation dose on risk of cardiovascular disease: A retrospective cohort study IntJSurg, vol.53, pp.345-349, 2018.

G. Giaccone, J. Thompson, and J. Crawford, Pembrolizumab in patients with recurrent thymic carcinoma: results of a phase II study, J Clin Oncol, vol.35, p.8573, 2017.

N. Girard, Use of immune checkpoint inhibitors in thymic epithelial tumors

. Mediastinum, , vol.2, p.34, 2018.

C. Basse, S. Thureau, S. Bota, E. Dansin, P. A. Thomas et al.,

, Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort

, J Thorac Oncol, vol.12, issue.11, pp.1715-1722, 2017.

J. D. Brierly, M. K. Gospodarowicz, C. Wittekind, and . Thymic-tumors, TNM classification of malignant tumors. 8th Edition, p.74, 2017.

Q. Liu, Z. Gu, F. Yang, J. Fu, Y. Shen et al., The role of postoperative radiotherapy for stage I/II/III thymic tumor-results of the ChART retrospective database, J Thorac Di.s, vol.8, pp.687-695, 2016.

Y. Wang, L. Xu, T. Du, Y. Gao, Z. Wu et al., A Nomogram Predicting Recurrence and Guiding Adjuvant Radiation for Thymic Carcinoma After Resection, Ann Thorac Surg, vol.106, pp.257-263, 2018.

G. Kleikamp, U. Schnepper, and R. Körfer, Coronary artery and aortic valve disease as a longterm sequel of mediastinal and thoracic irradiation, Thorac Cardiovasc Surg, 1997.

E. Yeoh, R. H. Holloway, A. Russo, M. Tippett, H. Bermingham et al., Effects of mediastinal irradiation on oesophageal function, Gut, vol.38, issue.2, pp.166-70, 1996.

T. Shulimzon, S. Apter, and R. Weitzen, Radiation pneumonitis complicating mediastinal radiotherapy postpneumonectomy, Eur Respir J, vol.9, issue.12, pp.2697-2706, 1996.

N. Girard, F. Mornex, P. Van-houtte, and J. F. Cordier, Thymoma: a focus on current therapeutic management, J Thorac Oncol, vol.4, pp.119-126, 2009.

N. Girard, E. Ruffini, A. Marx, C. Faivre-finn, and S. Peters, Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.26, issue.5, pp.40-55, 2015.

W. B. Travis, A. Brambilla, A. P. Burke, A. Marx, and A. Nicholson, WHO histological classification of tumours of the thymus. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, p.183, 2015.

F. C. Detterbeck, A. G. Nicholson, K. Kondo, P. Van-schil, and C. Moran, The Masaoka-Koga Stage Classification for Thymic Malignancies: Clarification and Definition of Terms, J Thorac Oncol, vol.6, pp.1710-1716, 2011.

J. D. Brierly, M. K. Gospodarowicz, C. Wittekind, and . Thymic-tumors, TNM classification of malignant tumors. 8th Edition, p.74, 2017.

F. C. Detterbeck, K. Stratton, D. Giroux, H. Asamura, J. Crowley et al., The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidencebased stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors, J Thorac Oncol, vol.9, issue.9, pp.65-72, 2014.

F. C. Detterbeck, Towards a TNM based prognostic classification for thymic tumours, J Thorac Oncol, vol.8, p.68, 2013.

A. Rimner, D. R. Gomez, A. J. Wu, W. Shi, E. D. Yorke et al., Failure patterns relative to radiation treatment fields for stage II-IV thymoma, J Thorac Oncol, vol.9, pp.403-409, 2014.

, NCCN Clinical Practice Guidelines in Oncology. Thymic malignancies, 2017.

E. Ruffini, F. Detterbeck, D. Van-raemdonck, R. G. Thomas, P. Weder et al.,

, Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database, Eur J Cardiothorac Surg, vol.46, pp.361-368, 2014.

M. Omasa, H. Date, T. Sozu, T. Sato, K. Nagai et al., Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study, Cancer, vol.121, pp.1008-1016, 2015.

J. A. Forquer, N. Rong, A. J. Fakiris, P. J. Loehrer, . Sr et al., Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease, Int J Radiat Oncol Biol Phys, vol.76, pp.440-445, 2010.

U. Ahmad, X. Yao, F. Detterbeck, J. Huang, A. Antonicelli et al., Thymic carcinoma outcomes and prognosis: results of an international analysis, J Thorac Cardiovasc Surg, vol.149, pp.95-100, 2015.

E. Ruffini, F. Detterbeck, D. Van-raemdonck, R. G. Thomas, P. Weder et al., Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database, J Thorac Oncol, vol.9, pp.541-548, 2014.

R. J. Korst, A. L. Kansler, P. J. Christos, and S. Mandal, Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis, Ann Thorac Surg, vol.87, pp.1641-1647, 2009.

A. Rimner, X. Yao, J. Huang, A. Antonicelli, U. Ahmad et al., Postoperative Radiation Therapy is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma -An Analysis of the International Thymic Malignancies Interest Group Retrospective Database, J Thorac Oncol, vol.11, pp.1785-1792, 2016.

Q. Liu, Z. Gu, F. Yang, J. Fu, Y. Shen et al., The role of postoperative radiotherapy for stage I/II/III thymic tumor-results of the ChART retrospective database, J Thorac Di.s, vol.8, pp.687-695, 2016.

N. Girard, E. Dansin, H. Léna, E. Pichon, P. A. Thomas et al., Systemic Treatment in Advanced Thymic Epithelial Tumors. Insights From a Prospective Cohort of 1000 Patients enrolled in RYTHMIC. International Association for the Study of Lung Cancer, World Conference on Lung Cancer, 2015.

U. Denver and . Citation, J Thorac Oncol, vol.10, p.353, 2015.

C. Basse, S. Thureau, S. Bota, E. Dansin, P. A. Thomas et al., Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort, J Thorac Oncol, vol.12, pp.1715-1722, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01667513

Y. Wang, L. Xu, T. Du, Y. Gao, Z. Wu et al., A Nomogram Predicting Recurrence and Guiding Adjuvant Radiation for Thymic Carcinoma After Resection, Ann Thorac Surg, vol.106, pp.257-263, 2018.

C. A. Weis, X. Yao, Y. Deng, F. C. Detterbeck, M. Marino et al., The impact of thymoma histotype on prognosis in a worldwide database, J Thorac Oncol, vol.10, p.367, 2015.